Volume 19, Number 8—August 2013
Perspective
Norovirus Disease in the United States
Table 1
Studies estimating incidence of norovirus disease, United States*
Study (reference) | Age group, y | Norovirus-associated outcome | Data source | Data period | Method |
---|---|---|---|---|---|
Mead et al. (4) | All | Deaths, hospitalizations, illnesses | NHDS, FoodNet | 1979–1997 | Attributable proportion extrapolation |
Patel et al. (2) | <5 | Hospitalizations, ED visits, outpatient visits | NHDS, NAMCS/NHAMCS | 1993–2002 | Attributable proportion extrapolation |
Scallan et al. (6) | All | Deaths, hospitalizations, illnesses | NVSS, HCUP-NIS, NHDS, NAMCS/NHAMCS, FoodNet | 2000–2006 | Attributable proportion extrapolation |
Hall et al. (7) | All | Outpatient visits, illnesses | HMO passive surveillance, FoodNet | 2004–2005 | Laboratory-confirmed population-based surveillance |
Payne et al. (8) | <5 | Hospitalizations, ED visits, outpatient visits | NVSN active surveillance, NAMCS/NHAMCS | 2008–2010 | Laboratory-confirmed population-based surveillance |
Hall et al. (9) | <5, 5–64, ≥65 | Deaths | NVSS | 1999–2007 | Indirect attribution from regression modeling |
Lopman et al. (10) | <5, 5–17, 18–64, 65–74, 75–84, ≥85 | Hospitalizations | HCUP-NIS | 1996–2007 | Indirect attribution from regression modeling |
Gastañaduy et al. (11) | <5, 5–17, 18–64, ≥65 | ED visits, outpatient visits | MarketScan | 2001–2009 | Indirect attribution from regression modeling |
*NHDS, National Hospital Discharge Survey; ED, emergency department; NAMCS/NHAMCS, National Ambulatory Medical Care Survey/National Hospital Ambulatory Medical Care Survey; NVSS, National Vital Statistics System; HCUP-NIS, Healthcare Cost Utilization Project Nationwide Inpatient Sample; FoodNet, Foodborne Diseases Active Surveillance Network; HMO, health maintenance organization; NVSN, New Vaccine Surveillance Network.
References
- Matthews JE, Dickey BW, Miller RD, Felzer JR, Dawson BP, Lee AS, The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup. Epidemiol Infect. 2012;140:1161–72 and. DOIPubMedGoogle Scholar
- Yen C, Hall AJ. Challenges to estimating norovirus disease burden. J Pediatr Infect Dis Soc. 2013;2:61–2
- Richardson C, Bargatze RF, Goodwin R, Mendelman PM. Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis. Expert Rev Vaccines. 2013;12:155–67 and. DOIPubMedGoogle Scholar
- National Center for Health Statistics. National health care surveys, January 24, 2013 [cited 2013 Mar 12]. http://www.cdc.gov/nchs/dhcs.htm
- Verhoef L, Koopmans M, Van Pelt W, Duizer E, Haagsma J, Werber D, The estimated disease burden of norovirus in the Netherlands. [Epub ahead of print].. Epidemiol Infect. 2012;•••:1–11.PubMedGoogle Scholar
- Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D, Iturriza-Gomara M, Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am J Epidemiol. 2010;171:1014–22 and. DOIPubMedGoogle Scholar
- Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2012;61:69–77 and. DOIPubMedGoogle Scholar
- Karsten C, Baumgarte S, Friedrich AW, von Eiff C, Becker K, Wosniok W, Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis. 2009;28:935–43 and. DOIPubMedGoogle Scholar
- Thomas MK, Murray R, Flockhart L, Pintar K, Pollari F, Fazil A, Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006. Foodborne Pathog Dis. 2013 May 9 [Epub ahead of print]
- Patel MM, Tate JE, Selvarangan R, Daskalaki I, Jackson MA, Curns AT, Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. Pediatr Infect Dis J. 2007;26:914–9 and. DOIPubMedGoogle Scholar
- Zheng DP, Widdowson MA, Glass RI, Vinje J. Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol. 2010;48:168–77 and. DOIPubMedGoogle Scholar
- Yen C, Wikswo ME, Lopman BA, Vinje J, Parashar UD, Hall AJ. Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis. 2011;53:568–71 and. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Norovirus activity—United States, 2006–2007. MMWR Morb Mortal Wkly Rep. 2007;56:842–6 .PubMedGoogle Scholar
Page created: July 18, 2013
Page updated: July 18, 2013
Page reviewed: July 18, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.